Skip to main content

Table 1 Commonly used anti-malarial drugs of patients attending St. Mary’s Hospital Lacor, Gulu (information obtained from excluded patients)

From: Recovery and stable persistence of chloroquine sensitivity in Plasmodium falciparum parasites after its discontinued use in Northern Uganda

Pretreatment drug, n (%)

2013

(N = 47)

2014

(N = 96)

2015

(N = 23)

2016

(N = 8)

2017

(N = 7)

Total

(N = 181)

Artemether (intramuscular)

1 (2.1)

0

0

0

0

1 (0.6)

Artesunate (intravenous)

0

2 (2.1)

2 (8.7)

0

0

4 (2.2)

Chloroquine

3 (6.4)

1 (1.0)

0

0

0

4 (2.2)

Artemether–lumefantrine

34 (72.3)

67 (69.8)

6 (26.1)

7 (85.7)

6 (85.7)

120 (66.3)

Sulfadoxine–pyrimethamine

2 (4.3)

5 (5.2)

1 (4.4)

0

0

8 (4.4)

Quinine

6 (12.8)

6 (6.3)

1 (4.4)

1 (14.3)

0

14 (7.7)

Artesunate and artemether lumefantrine

0

1 (1.0)

0

0

0

1 (0.6)

Artemether–lumefantrine and sulfadoxine–pyrimethamine

0

1 (1.0)

0

0

0

1 (0.6)

Artemether–lumefantrine and quinine

0

3 (3.1)

0

0

0

3 (1.7)

Unknown

1 (2.1)

10 (10.4)

13 (57.0)

0

1 (14.3)

25 (13.8)